MAI Capital Management - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 15 filers reported holding CLOVIS ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MAI Capital Management ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2023$2,176
+106.3%
20,0000.0%0.00%
Q4 2022$1,055
-95.6%
20,0000.0%0.00%
Q3 2022$24,000
-33.3%
20,0000.0%0.00%
-100.0%
Q2 2022$36,000
-10.0%
20,0000.0%0.00%0.0%
Q1 2022$40,000
-25.9%
20,0000.0%0.00%0.0%
Q4 2021$54,000
+20.0%
20,000
+100.0%
0.00%0.0%
Q3 2021$45,000
-22.4%
10,0000.0%0.00%0.0%
Q2 2021$58,000
-17.1%
10,0000.0%0.00%
-50.0%
Q1 2021$70,00010,0000.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 150,000$1,564,0004.60%
Healthcare Value Capital, LLC 100,000$1,043,0003.07%
Palo Alto Investors LP 5,056,286$52,712,0002.90%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,328,200$13,848,0001.53%
Ikarian Capital, LLC 513,700$5,355,0000.87%
Pinz Capital Management, LP 207,800$2,166,0000.79%
Leap Investments LP 146,300$1,525,0000.72%
Elk Creek Partners, LLC 574,616$5,990,0000.69%
SECTOR GAMMA AS 408,625$4,260,0000.68%
Artal Group S.A. 1,000,000$10,425,0000.40%
View complete list of CLOVIS ONCOLOGY INC shareholders